Trial Profile
The Effects of Biologic Therapy With Disease Activity and Circadian Rhythm
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 12 Jun 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 12 Jun 2019 Planned End Date changed from 30 Jun 2019 to 16 Aug 2019.
- 14 Jan 2019 Planned primary completion date changed from 31 Dec 2018 to 30 Jun 2019.